Cardiosense

About:

Cardiosense is a digital biomarker platform that provides multi-sensor devices and proprietary algorithms to detect early signs of diseases.

Website: https://www.cardiosense.com

Twitter/X: cardiosenseinc

Top Investors: Broadview Ventures, Hatteras Venture Partners, Laerdal Million Lives Fund, OSF Ventures, Portal Innovations

Description:

Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. They mine raw biosignals for unprecedented visibility into cardiac functions. They also develop an advanced signal processing pipeline to identify pre-symptomatic markers of cardiac disease.

Total Funding Amount:

$15.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Chicago, Illinois, United States

Founded Date:

2020-05-01

Contact Email:

contact(AT)cardiosense.com

Founders:

Amit Gupta, Andrew Carek

Number of Employees:

11-50

Last Funding Date:

2022-12-08

IPO Status:

Private

© 2024 MyAiNote.com